Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Endocrinology
•
Pituitary Disorders
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
Answer from: at Community Practice
If patient does not desire fertility and microprolactinoma is stable or smaller, cabergoline can be tapered off.
Sign in or Register to read more
21564
Related Questions
When do you check macroprolactin in the evaluation of hyperprolactinemia?
Can combined oral contraceptive use cause falsely elevated 24-hour urine-free cortisol?
Does preoperative use of somatostatin receptor ligand improve remission rates after surgery for acromegaly?
How do you approach monitoring for autoimmune disorders in patients with surgical remission of Cushing’s disease, given the higher incidence of autoimmune disease in this population?
Should patients with asymptomatic GH deficiency be treated with GH replacement therapy if they have prior known severe CAD?
Should oral combined contraceptives be held prior to overnight dexamethasone suppression test to rule out Cushings?
Given the new 2022 WHO classification of pituitary tumors, should we be regularly counseling our patients about the risk of malignancy for what we previously referred to as pituitary adenomas but now classified as pituitary neuroendocrine tumors (PitNETs)?
What specific clinical factors would drive you to recommend surgical intervention for patients with small, nonfunctional pituitary adenomas who exhibit no neurological symptoms?
Does caution have to be used in GH replacement therapy in any and all types of cancer history?
For a TSH producing microadenoma, would you recommend surgery vs methimazole if the patient is elderly and the tumor is relatively small?